Abivax SA (ABVX)
NASDAQ: ABVX · IEX Real-Time Price · USD
11.86
+0.04 (0.34%)
Jul 26, 2024, 4:30 PM EDT - Market closed
Abivax Market Cap
Abivax has a market cap or net worth of $750.33 million as of July 26, 2024.
Market Cap
750.33M
Enterprise Value
541.27M
1-Year Change
n/a
Ranking
Category
Stock Price
$11.86
Market Cap Chart
Since October 20, 2023, Abivax's market cap has increased from $521.80M to $750.33M, an increase of 43.80%. That is a compound annual growth rate of 60.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 743.80M | 10.57% |
| Dec 29, 2023 | 672.70M | 28.92% |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OrthoPediatrics | 776.82M |
| Evolus | 770.74M |
| Phibro Animal Health | 764.71M |
| Zymeworks | 760.08M |
| Travere Therapeutics | 752.92M |
| ArriVent BioPharma | 749.59M |
| SIGA Technologies | 748.21M |
| Scholar Rock Holding | 740.12M |